Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
That tells us something important about the demand for effective weight loss options and how we need to think about supporting such patients. The study also found that about two-thirds of respondents (67%) reported weight loss or reduced appetite or food cravings while using semaglutide, aligning with clinical trial findings
Dosing is gradually increased to the 2.4 mg maintenance dose, unless you and your clinician decide otherwise
Its crucial to discuss with a healthcare provider before any changes in dosage to tailor the treatment to personal needs and ensure safety
In one pivotal trial, participants who received semaglutide injections lost an average of 15% of their body weight over 68 weeks, compared to a 2.4% weight loss in the placebo group
This innovative technology not only enhances patient compliance but also minimizes gastrointestinal side effects often associated with oral medications
